Hologic Inc. Files 8-K on Financials
Ticker: HOLX · Form: 8-K · Filed: Jan 13, 2025 · CIK: 859737
| Field | Detail |
|---|---|
| Company | Hologic INC (HOLX) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, results-of-operations
Related Tickers: HOLX
TL;DR
Hologic dropped its 8-K, check the financials for Jan 12.
AI Summary
Hologic, Inc. filed an 8-K on January 13, 2025, reporting on its Results of Operations and Financial Condition as of January 12, 2025. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This filing provides investors with crucial updates on Hologic's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate negative or positive news indicated.
Key Players & Entities
- HOLOGIC INC (company) — Registrant
- January 12, 2025 (date) — Date of earliest event reported
- January 13, 2025 (date) — Date of Report
- DELAWARE (jurisdiction) — State of Incorporation
- 001-36214 (identifier) — SEC File Number
- 250 Campus Drive, Marlborough, Massachusetts 01752 (address) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K reports on 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is January 12, 2025.
When was this 8-K filing submitted to the SEC?
The filing was submitted on January 13, 2025.
What is Hologic, Inc.'s principal executive office address?
Hologic, Inc.'s principal executive office is located at 250 Campus Drive, Marlborough, Massachusetts 01752.
Under which section of the Securities Exchange Act is this report filed?
This Current Report is filed Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 08:24:00
Filing Documents
- ef20041439_8k.htm (8-K) — 30KB
- ef20041439_ex99-1.htm (EX-99.1) — 36KB
- image0.jpg (GRAPHIC) — 1KB
- 0001140361-25-000881.txt ( ) — 208KB
- holx-20250112.xsd (EX-101.SCH) — 4KB
- holx-20250112_lab.xml (EX-101.LAB) — 21KB
- holx-20250112_pre.xml (EX-101.PRE) — 16KB
- ef20041439_8k_htm.xml (XML) — 4KB
02
Item 2.02 Results of Operations and Financial Condition. On January 12, 2025, Hologic, Inc. issued a press release announcing its preliminary revenue results for the first quarter ended December 28, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise Cautionary Note Regarding Forward-Looking to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated January 12, 2025, of Hologic, Inc. announcing its preliminary revenue results for the first quarter ended December 28, 2024. 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 12, 2025 HOLOGIC, INC. By: /s/ Karleen M. Oberton Karleen M. Oberton Chief Financial Officer